The midterm elections are upon us. As both parties scramble to make their last appeals to voters, they may be overlooking a key demographic among voting Americans — one that could have a significant affect on the outcome of the elections. Recent polling shows just how influential this new voting bloc could be. The question is, who will seize on the opportunity to reach these voters?

The numbers from Cygnal’s latest polling are eye-opening. A significant segment of the American public is now using GLP-1 medications — drugs such as Ozempic and Wegovy — to manage weight and improve metabolic health. What started as a niche diabetes treatment has become a cultural and political phenomenon. Millions of Americans are quietly transforming their lives, and this shift is creating a new constituency that both parties ignore at their peril.